Results 91 to 100 of about 32,964 (245)

Greedy power allocation for multicarrier systems with reduced complexity [PDF]

open access: yes, 2010
In this paper we consider a reduced complexity discrete bit loading for Multicarrier systems based on the greedy power allocation (GPA) under the constraints of transmit power budget, target BER, and maximum permissible QAM modulation order.
Al-Hanafy, Waleed, Weiss, S.
core   +3 more sources

Cardiac effects of two hallucinogenic natural products, N,N-dimethyl-tryptamine and 5-methoxy-N,N-dimethyl-tryptamine

open access: yesScientific Reports
It is unclear whether hallucinogenic tryptamine derivatives namely N,N-dimethyl-tryptamine (DMT) and 5-methoxy-N,N-dimethyl-tryptamine (5-MeO-DMT) exert positive inotropic effects in the human heart.
Joachim Neumann   +4 more
doaj   +1 more source

The Effect of Disease Modifying Therapies on Disability Progression in Multiple Sclerosis: A Systematic Overview of Meta-Analyses

open access: yesFrontiers in Neurology, 2019
Background: Disease modifying therapy (DMT) efficacy trials make an essential contribution to the development of evidence-based clinical treatments and practices for people with multiple sclerosis (MS).
Suzi B. Claflin   +2 more
doaj   +1 more source

Traces of the Other – Are DMT Entities Real? DMT Phenomenology in the Framework of Conscious Realism

open access: yes
Encounters with apparently autonomous and intelligent non-human entities are a striking and recurrent feature of high-dose N,N-dimethyltryptamine (DMT) experi-ences.
Niffe Hermansson   +2 more
core   +6 more sources

Disease-modifying therapy initiation patterns in multiple sclerosis in three large MS populations

open access: yesTherapeutic Advances in Neurological Disorders
Background: Treatment guidelines recommend early disease-modifying therapy (DMT) initiation after diagnosis of multiple sclerosis (MS). Multinational comparative studies that assess time to DMT initiation in MS may allow detection of barriers inherent to
Alexander Stahmann   +10 more
doaj   +1 more source

The Theoretical Schema of Dance Movement Therapy: From Medical Body Philosophy to Therapeutic Practice

open access: yesYixue yu zhexue
In response to the insufficient theoretical foundation of dance movement therapy (DMT), this study proposes a theoretical schema through interdisciplinary research integrating the philosophy of the medical body and DMT.
Wen LIU, Hong LIU
doaj   +1 more source

Inter‐ and intraspecific variation in theropod dinosaur dental microwear and its palaeoecological implications

open access: yesThe Anatomical Record, EarlyView.
Abstract Differences in skull and tooth morphology, stomach contents, and estimated bite force between medium‐to‐large sized (≥100 kg) predatory theropod dinosaurs have long been suspected to correlate with differences in their diets and dietary guilds (e.g., hypercarnivory, piscivory).
Cassius Morrison   +9 more
wiley   +1 more source

Ayahuasca and Its Main Component N,N-Dimethyltryptamine (DMT) for the Treatment of Mental Disorders: Mechanisms of Action, Clinical Studies, and Tools to Explore the Human Mind

open access: yesBiomedicines
In recent years, psychopharmacology has experienced a significant challenge, highlighting a renewed and strong scientific interest in psychedelics as breakthrough therapies for mental disorders.
Alice Melani   +9 more
doaj   +1 more source

Instrumented DMT: review and analysis [PDF]

open access: yes, 2015
Following the research of the Marchetti DMT, instrumented DMTs have been fabricated and investigated for different purposes such as automatic data acquisition, better understanding of the standard Marchetti DMT, dealing with difficult soils or achieving ...
Shen, Hao   +2 more
core  

Switching disease‐modifying therapies in patients with spinal muscular atrophy: A systematic review on effectiveness outcomes

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
With multiple disease‐modifying therapies now available, treatment switching has become an important clinical consideration in the management of spinal muscular atrophy (SMA). While some switches are prompted by suboptimal clinical response, more commonly they are driven by treatment burden, convenience, or adverse events.
Andrej Belančić   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy